Transition Therapeutics, Inc. (TTHI) - NASDAQ
From other sites
Company Description
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets. It operates through research and development of therapeutic agents segment. The company's products include ELND005 for the treatment of... More
Sector: Healthcare
Industry: Biotechnology
Country: Canada